Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer

Condition:   Advanced Ovarian Cancer Interventions:   Biological: AST-201;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Placebo;   Drug: rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor) Sponsor:   Aston Sci. Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials